|
Mandy Jackson
@
ScripMandy
San Diego, CA
|
|
I am Managing Editor, US Commercial News, for the Informa Pharma Insights publications Scrip and The Pink Sheet. Views expressed here are strictly my own.
|
|
|
16.643
Tweetovi
|
676
Pratim
|
4.491
Osobe koje vas prate
|
| Tweetovi |
| Mandy Jackson proslijedio/la je tweet | ||
|
a16z
@a16z
|
4. velj |
|
We said we'd never do bio. Today, we launched Bio Fund III. Here's why we changed our minds: bit.ly/2OrLTU2
From a16z Bio general partners:
@vintweeta
@JorgeCondeBio
@vijaypande
@julesyoo
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
4. velj |
|
$GILD CAR-T Yescarta sales flattening out. twitter.com/bradloncar/sta…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
3. velj |
|
Same here pic.twitter.com/hyLEs7gPSo
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
3. velj |
|
😮🥶🌴☁️💨🌊 twitter.com/grobbins/statu…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
3. velj |
|
College journalism programs should put more emphasis on business and trade publications. These are also fulfilling journalism jobs and the hours and/or pay generally are better - especially for working parents.
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
31. sij |
|
A lot of new PR pros started following me during #JPM20. So, a reminder: @PharmaScrip & @PharmaPinkSheet only cover drugs, not medical devices or diagnostics, but our colleagues at @Medtech_Insight would love to receive your device & diagnostic news: medtech.pharmaintelligence.informa.com/meet-the-team
|
||
|
|
||
| Mandy Jackson proslijedio/la je tweet | ||
|
Odi Bruckman
@odibro
|
31. sij |
|
$BMY Withdraws European Application of Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer businesswire.com/news/home/2020…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
31. sij |
|
$GILD “Gilead is working closely with global health authorities to respond to the novel coronavirus (2019-nCoV) outbreak through the appropriate experimental use of our investigational compound remdesivir.” gilead.com/news-and-press… twitter.com/AndyBiotech/st…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
31. sij |
|
$LLY Reyvow and $AGN Ubrelvy both have launched. Allergan confirmed that its acute #migraine drug is available in pharmacies and prescriptions are being filled. twitter.com/scripmandy/sta…
|
||
|
|
||
| Mandy Jackson proslijedio/la je tweet | ||
|
Renaissance Capital
@IPOtweet
|
31. sij |
|
|
||
|
|
||
| Mandy Jackson proslijedio/la je tweet | ||
|
Renaissance Capital
@IPOtweet
|
30. sij |
|
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
31. sij |
|
“A benefit of ditans, like Lilly’s Reyvow, is that they are not associated with vasoconstriction, which is seen with triptans, making the older drugs contraindicated in patients with cardiovascular disease.” (Subscription required) scrip.pharmaintelligence.informa.com/SC141524/Marke…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
31. sij |
|
$LLY Reyvow list price for the on-demand migraine treatment is $640 for a package of 8 tablets (on par with $85/dose for $AGN CGRP Ubrelvy). scrip.pharmaintelligence.informa.com/SC141541/The-I…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
31. sij |
|
$LLY Is launching its acute migraine drug Reyvow (lasmiditan) now that it has received DEA scheduling - class V, the lowest potential for abuse. prnewswire.com/news-releases/…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
30. sij |
|
$AMGN Murdo Gordon: Over 92% of commercial lives have access to migraine prevention drug Aimovig with affordable co-pay. More than 80% of prescriptions are paid. Reduction in net selling price in Q1 due to new CVS deal, but stabilizing the rest of the year.
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
30. sij |
|
$AMGN David Reese pipeline updates in line w/those in this @PharmaScrip story based on my chat w/the EVP of R&D at #JPM20 about Amgen's efforts to work more efficiently, including through use of genomics, proteomics and transcriptomics (subscription reqd). scrip.pharmaintelligence.informa.com/SC141559/Amgen…
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
30. sij |
|
|
||
|
Mandy Jackson
@ScripMandy
|
30. sij |
|
$AMGN Commercial EVP Murdo Gordon notes that Amgen will increase its focus on the psoriasis market now that its has two branded products in this market – Otezla and Enbrel, plus biosimilars.
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
30. sij |
|
$AMGN CFO Peter Griffith: Net 5% price decline globally in 2019, expect low to mid single-digit net price decline in 2020, which will be more than offset by increased revenue.
|
||
|
|
||
|
Mandy Jackson
@ScripMandy
|
30. sij |
|
$AMGN CEO Bob Bradway continues to note, as he did at #JPM20, that Asia-Pacific will be a major source of growth. Company sees it growing to 25% of its revenue. twitter.com/Amgen/status/1…
|
||
|
|
||